ABC294640
ABC-102
Phase 2 small_molecule terminated
Quick answer
ABC294640 for Diffuse Large B Cell Lymphoma is a Phase 2 program (small_molecule) at Apogee Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apogee Therapeutics
- Indication
- Diffuse Large B Cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated